Surface Oncology Inc (SURF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 30,000 | 154 | 392 | 515 | 1,626 |
| Gross Profit | 30,000 | 154 | 392 | 515 | 1,626 |
| Operating Expenses | 23,164 | 23,528 | 19,884 | 19,103 | 16,185 |
| Operating Income | 6,836 | -23,374 | -19,492 | -18,588 | -14,559 |
| Other Income | -637 | -676 | -401 | -393 | -1,002 |
| Pre-tax Income | 6,199 | -24,050 | -19,893 | -18,981 | -15,561 |
| Net Income Continuous | 6,199 | -24,050 | -19,893 | -18,981 | -15,561 |
| Net Income | $6,199 | $-24,050 | $-19,893 | $-18,981 | $-15,561 |
| EPS Basic Total Ops | 0.13 | -0.52 | -0.44 | -0.44 | -0.37 |
| EPS Basic Continuous Ops | 0.13 | -0.53 | -0.44 | -0.44 | -0.37 |
| EPS Diluted Total Ops | 0.13 | -0.52 | -0.44 | -0.44 | -0.37 |
| EPS Diluted Continuous Ops | 0.12 | -0.53 | -0.44 | -0.44 | -0.37 |
| EPS Diluted Before Non-Recurring Items | 0.13 | -0.52 | -0.44 | N/A | N/A |
| EBITDA(a) | $7,359 | $-22,778 | $-18,871 | $-17,977 | $-14,011 |